Intravenous Solutions Industry Forecast to Hit $20.1 Billion by 2029 With a Strong 7.7% CAGR

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Intravenous Solutions Market?

The market for intravenous solutions has experienced robust growth over the past few years. Projections indicate it will expand from $14 billion in 2024 to $14.91 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.5%. Historically, this growth has been driven by factors such as an increase in surgical procedures, the rising occurrence of chronic diseases, the expansion of home healthcare services, strict regulations that ensure product safety, a greater emphasis on patient hydration, and worldwide emergency preparedness efforts.

The intravenous solutions market is anticipated to experience substantial expansion in the coming years. It is projected to reach “$20.1 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is driven by factors such as demographic shifts including population growth and an aging populace, a rise in surgical procedures, an escalating prevalence of infectious diseases, the adoption of telemedicine and remote patient monitoring, a heightened emphasis on preventive healthcare, investments in global health security, and evolving patient-centric care models. Key developments expected in this period include a greater need for parenteral nutrition solutions, increased acceptance of pre-mixed iv solutions, the broadening scope of home infusion therapies, the availability of electrolyte-balanced solutions, the introduction of new drug additives and adjuncts, and the integration of intelligent iv systems for monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

Which Factors And Drivers Are Influencing The Intravenous Solutions Market In 2025?

The expanding occurrence of cancer is anticipated to propel the future growth of the intravenous solutions market. Cancer encompasses a range of diseases defined by unchecked cell proliferation, the capacity to infiltrate surrounding tissues, and spread to other body parts. Intravenous solutions are frequently utilized in cancer treatment for delivering chemotherapy drugs and ensuring hydration during therapy. For instance, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, projected that by 2050, over 35 million new cancer cases would arise, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the escalating prevalence of cancer is a significant factor driving the expansion of the intravenous solutions market.

What Are The Major Segment Types Covered In The Intravenous Solutions Market?

The intravenous solutionsmarket covered in this report is segmented –

1) By Product: Total Parenteral Nutrition; Peripheral Parenteral Nutrition

2) By Nutrients: Carbohydrates; Vitamins And Minerals; Single Dose Amino Acids; Parenteral Lipid Emulsion; Other Nutrients

3) By Application: Basic Intravenous (IV) Solution; Nutritional Intravenous (IV) Solution; Blood Intravenous (IV) Solution; Drug Intravenous (IV) Solution; Irrigation Intravenous (IV) Solution

4) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Home Care Settings

Subsegments:

1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions; Multivitamin Solutions

2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions; Amino Acid Solutions; Lipid Solutions; Electrolyte Solutions

How Are Emerging Market Trends Shaping The Intravenous Solutions Industry Landscape?

Major companies operating within the intravenous solutions market are prioritizing the creation of innovative syringes, such as pre-filled and ready-to-administer variants, to secure a competitive advantage. These pre-filled and ready-to-administer syringes arrive preloaded with medication, designed for immediate application without the need for manual filling or preparation. Illustratively, in August 2023, GENIXUS Corp., a US-based healthcare enterprise, launched KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. These syringes are constructed from a transparent, durable polymer material, thereby eliminating the risks traditionally linked with glass syringes. Being pre-filled and ready to administer, they provide benefits such as time savings and a reduction in medication errors. Rocuronium bromide injection is intended strictly for intravenous use. It incorporates several crucial attributes, including RFID-enabled compatibility with KitCheck, which represents the latest kit and tray management technology, along with intuitive labeling and a color-coded plunger rod to facilitate swift identification.

Which Major Firms Are Strengthening Their Position In The Intravenous Solutions Industry?

Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

Which Regional Markets Are Contributing Most To The Intravenous Solutions Industry Expansion?

North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Intravenous Solutions Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

Browse Through More Reports Similar to the Global Intravenous Solutions Market 2025, By The Business Research Company

Intravenous Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Intravenous Immunoglobulin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Intravenous Iv Hydration Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-iv-hydration-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795